Jubilant Pharmova Ltd. - Research Center
530019 JUBLPHARMA Group (A) BSE data
Results
Statement
More
| Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Equity share capital
| 15.90 |
15.93 |
15.93 |
15.93 |
15.93 |
Share application money
Preference share capital
Reserves & surplus
| 2,358.60 |
2,398.62 |
1,265.89 |
1,266.52 |
2,591.37 |
Secured loans
| 342.90 |
301.50 |
499.00 |
493.00 |
1,950.89 |
Unsecured loans
Total
| 2,717.40 |
2,716.05 |
1,780.82 |
1,775.45 |
4,558.18 |
Gross block
| 995.90 |
946.47 |
148.21 |
148.93 |
2,277.53 |
Less : revaluation reserve
Less : accumulated depreciation
| 284.60 |
259.07 |
24.67 |
21.85 |
412.81 |
Net block
| 711.30 |
687.40 |
123.54 |
127.08 |
1,864.72 |
Capital work-in-progress
| 37.00 |
46.97 |
0.06 |
0.33 |
59.09 |
Investments
| 1,656.90 |
1,656.57 |
1,645.75 |
1,645.98 |
1,764.03 |
Current assets, loans & advances
| 586.70 |
617.54 |
60.12 |
71.20 |
1,745.55 |
Less : current liabilities & provisions
| 274.50 |
292.42 |
48.65 |
69.15 |
875.21 |
Total net current assets
| 312.20 |
325.12 |
11.47 |
2.05 |
870.34 |
Miscellaneous expenses not written
Total
| 2,717.40 |
2,716.05 |
1,780.82 |
1,775.45 |
4,558.18 |
Book value of unquoted investments
| 1,656.90 |
1,656.57 |
1,645.75 |
1,645.98 |
1,764.03 |
Market value of quoted investments
Contingent liabilities
| 92.00 |
116.26 |
69.70 |
70.39 |
478.39 |
Number of equity sharesoutstanding (Lacs)
| 1592.81 |
1592.81 |
1592.81 |
1592.81 |
1592.81 |